Pharmacokinetic Study of Milrinone in Babies With Persistent Pulmonary Hypertension of the Newborn

NATerminatedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

June 30, 2010

Primary Completion Date

February 28, 2013

Study Completion Date

May 31, 2015

Conditions
Persistent Fetal Circulation Syndrome
Interventions
DRUG

Milrinone Lactate

Milrinone lactate will be given first as an IV bolus over one hour at the assigned dose level, followed by a 24 hour IV infusion at the assigned dose level.

Trial Locations (2)

19104

The Children's Hospital of Philadelphia, Philadelphia

48201-2196

Children's Hospital of Michigan/Hutzel Women's Hospital, Detroit

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

University of Pennsylvania

OTHER

collaborator

Bedford Pharmaceuticals

INDUSTRY

collaborator

American Medical Association

OTHER

collaborator

Thrasher Research Fund

OTHER

lead

Children's Hospital of Philadelphia

OTHER